A critical breakthrough in cancer research is arising with the use of nanobodies to reactivate dysfunctional p53. This vital malignant protector protein is frequently disabled in various forms of tumors, leading https://thesocialcircles.com/story7770100/mini-antibodies-reactivate-the-p53-protein-the-promising-hope-for-cancer-management